C, O., A, P., ED, I., A, K., A, K., K, Z., . . . I, P. (2022). Allogeneic hematopoietic stem cell transplantation in infants is associated with significant morbidity and mortality. Pediatric transplantation, 26(4), e14239. https://doi.org/10.1111/petr.14239
Chicago Style (17th ed.) CitationC, Oikonomopoulou, et al. "Allogeneic Hematopoietic Stem Cell Transplantation in Infants Is Associated with Significant Morbidity and Mortality." Pediatric Transplantation 26, no. 4 (2022): e14239. https://doi.org/10.1111/petr.14239.
MLA (9th ed.) CitationC, Oikonomopoulou, et al. "Allogeneic Hematopoietic Stem Cell Transplantation in Infants Is Associated with Significant Morbidity and Mortality." Pediatric Transplantation, vol. 26, no. 4, 2022, p. e14239, https://doi.org/10.1111/petr.14239.